Literature DB >> 2056571

Transureteroureterostomy with cutaneous ureterostomy: a 25-year experience.

L M Rainwater1, F J Leary, C C Rife.   

Abstract

We reviewed 67 patients who underwent transureteroureterostomy with cutaneous ureterostomy for benign (32) and malignant (35) disease in regard to the indications for and complications of the procedure. The most common complications included urine leakage at the ureteroureterostomy, stomal stenosis and calculus formation. Renal function improved or remained stable in 75% of the patients. Transureteroureterostomy with cutaneous ureterostomy is a viable alternative diversion technique in a select group of patients.

Entities:  

Mesh:

Year:  1991        PMID: 2056571     DOI: 10.1016/s0022-5347(17)37702-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  End-to-end ureteral anastomosis: a simple alternative to cutaneous ureterostomy in selected patients.

Authors:  Paolo Panella; Pietro Pepe; Luigi Motta; Letterio D'Arrigo; Francesco Savoca; Giuseppe Candiano; Michele Pennisi; Francesco Aragona
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Evaluations for hydronephrosis after the establishment of tubeless cutaneous ureterostomy.

Authors:  Chul Jang Kim; Taichi Sano; Ryosuke Murai
Journal:  Korean J Urol       Date:  2013-03-15

3.  Diagnostic criteria for stomal obstruction of tubeless cutaneous ureterostomy by use of (99m)tc-mercaptoacetyltriglycine diuretic renography.

Authors:  Chul Jang Kim; Shigehisa Kubota; Ryosuke Murai
Journal:  Korean J Urol       Date:  2013-05-14

4.  The use of transureteroureterostomy during ureteral reconstruction for advanced primary or recurrent pelvic malignancy in the era of multimodal therapy.

Authors:  Junichiro Kawamura; Masaki Tani; Kimiaki Sumida; Takefumi Yazawa; Junya Kawasoe; Michihiro Yamamoto; Hideki Harada; Hidekazu Yamamoto; Masazumi Zaima
Journal:  Int J Colorectal Dis       Date:  2016-10-06       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.